Pfizer Inc. Q3 2025 Earnings Analysis
Revenue declined 5.9% year over year and rose 13.7% sequentially. Margins improved from the previous quarter, suggesting stronger cost discipline and operational efficiency. Year-over-year earnings remained under pressure, showing that the recovery in profitability is still incomplete.
Revenue trend
Revenue remains weak year over year, but sequential improvement suggests near-term stabilization.
Margin and earnings quality
Margins improved from last quarter, suggesting that cost controls are starting to offset topline weakness.
What matters next
The earnings story is shifting from pure growth toward efficiency, pricing discipline, and margin defense.
Revenue & YoY Growth
QuarterlyRevenue trend and year-over-year growth across recent reported quarterly periods.
Net Income & Net Margin
QuarterlyNet income and net margin trend over recent reported quarterly periods.
Revenue Analysis
Pfizer Inc. reported $16.7B in revenue for Q3 2025, down 5.9% YoY and up 13.7% QoQ. The result suggests that although topline pressure remains, quarterly demand may be starting to stabilize.
Profitability Analysis
Net income came in at $3.5B, down 20.8% YoY and up 21.7% QoQ. Net margin was 21.3%. Sequential margin improvement suggests stronger operating discipline despite a mixed revenue environment.
Frequently Asked Questions
Quick factual answers for this report. Need the why behind them? Ask the report assistant.
What was Pfizer Inc.'s revenue in Q3 2025?
Pfizer Inc. reported revenue of $16.7B in Q3 2025.
What was Pfizer Inc.'s net income in Q3 2025?
Pfizer Inc. reported net income of $3.5B in Q3 2025.
How did Pfizer Inc.'s revenue change year over year?
Pfizer Inc.'s revenue decreased by 5.9% year over year in Q3 2025.
What was Pfizer Inc.'s net margin in Q3 2025?
Pfizer Inc.'s net margin was 21.3% in Q3 2025.
Compare this quarter with the previous earnings report.
Explore company profile, industry, and historical context.
View more quarterly financial trend pages for this company.
Data Source & Methodology
Financial data is sourced from company filings and internal processed earnings data.
YoY and QoQ values are derived from reported quarterly figures when not directly available.
This page is for informational purposes only and does not constitute investment advice.
